首页> 美国卫生研究院文献>Springer Open Choice >Feeder layer- and animal product-free culture of neonatal foreskin keratinocytes: improved performance usability quality and safety
【2h】

Feeder layer- and animal product-free culture of neonatal foreskin keratinocytes: improved performance usability quality and safety

机译:新生儿包皮角质形成细胞无饲养层和动物产品的培养:改善的性能可用性质量和安全性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Since 1987, keratinocytes have been cultured at the Queen Astrid Military Hospital. These keratinocytes have been used routinely as auto and allografts on more than 1,000 patients, primarily to accelerate the healing of burns and chronic wounds. Initially the method of Rheinwald and Green was used to prepare cultured epithelial autografts, starting from skin samples from burn patients and using animal-derived feeder layers and media containing animal-derived products. More recently we systematically optimised our production system to accommodate scientific advances and legal changes. An important step was the removal of the mouse fibroblast feeder layer from the cell culture system. Thereafter we introduced neonatal foreskin keratinocytes (NFK) as source of cultured epithelial allografts, which significantly increased the consistency and the reliability of our cell production. NFK master and working cell banks were established, which were extensively screened and characterised. An ISO 9001 certified Quality Management System (QMS) governs all aspects of testing, validation and traceability. Finally, as far as possible, animal components were systematically removed from the cell culture environment. Today, quality controlled allograft production batches are routine and, due to efficient cryopreservation, stocks are created for off-the-shelf use. These optimisations have significantly increased the performance, usability, quality and safety of our allografts. This paper describes, in detail, our current cryopreserved allograft production process.
机译:自1987年以来,角质形成细胞已在阿斯特丽德女王军事医院培养。这些角质形成细胞已常规用于超过1000名患者的自体和同种异体移植,主要是为了促进烧伤和慢性伤口的愈合。最初,Rheinwald和Green的方法用于制备培养的上皮自体移植物,从烧伤患者的皮肤样品开始,并使用动物衍生的饲养层和含有动物衍生产品的培养基。最近,我们系统地优化了生产系统,以适应科学进步和法律变化。重要的一步是从细胞培养系统中去除小鼠成纤维细胞饲养层。此后,我们引入了新生的包皮角质形成细胞(NFK)作为培养的上皮同种异体移植的来源,这大大提高了我们细胞生产的一致性和可靠性。建立了NFK主细胞库和工作细胞库,并对其进行了广泛的筛选和表征。经过ISO 9001认证的质量管理系统(QMS)控制着测试,验证和可追溯性的各个方面。最后,尽可能从细胞培养环境中有系统地去除动物成分。如今,质量受控的同种异体移植生产批次已成为常规生产,并且由于有效的低温保存,可以为现成的库存创建库存。这些优化极大地提高了同种异体移植的性能,可用性,质量和安全性。本文详细介绍了我们当前冷冻保存的同种异体移植物的生产过程。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号